Evidence map›Paper›PMID 26613786›Full record

ArticleMolecular biology and evolution2016

Emergence of Antimicrobial-Resistant Escherichia coli of Animal Origin Spreading in Humans.

David Skurnik, Olivier Clermont, Thomas Guillard, Adrien Launay, Olga Danilchanka, Stéphanie Pons, Laure Diancourt, François Lebreton, Kristina Kadlec, Damien Roux and 12 more

Abstract read
In one paragraph

Article in Molecular biology and evolution, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed.

  1. Article
  2. Article
  3. Whole-Genome Analysis ofAntibiotics (Basel, Switzerland) · 2025
    Article
  4. Article
  5. Article
  6. Genomic dissection ofISME communications · 2024
    Article
  7. Article
  8. Article
  9. Antimicrobial Resistance and Clonal Lineages ofAntibiotics (Basel, Switzerland) · 2023
    Review
  10. Article
  11. Article
  12. Genetic characterization ofAccess microbiology · 2023
    Article
  13. Article
  14. Multidrug-Resistant High-RiskAntibiotics (Basel, Switzerland) · 2022
    Article
  15. Article
  16. Highly Virulent and Multidrug-ResistantAntibiotics (Basel, Switzerland) · 2022
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

David SkurnikDivision of Infectious Diseases, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA INSERM, IAME, UMR 1137, Paris, France Univ Paris Diderot, IAME, Sorbonne Paris Cité, UMR 1137, Faculté De Médecine, Site Xavier Bichat, Paris, France French National Reference Center for Bacterial Resistance in Commensal Flora, Laboratory of Bacteriology, Bichat-Claude Bernard Hospital, Assistance Publique-Hôpitaux De Paris, Paris, France dskurnik@rics.bwh.harvard.edu erick.denamur@inserm.fr.
Olivier ClermontINSERM, IAME, UMR 1137, Paris, France Univ Paris Diderot, IAME, Sorbonne Paris Cité, UMR 1137, Faculté De Médecine, Site Xavier Bichat, Paris, France.
Thomas GuillardDivision of Infectious Diseases, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Adrien LaunayINSERM, IAME, UMR 1137, Paris, France Univ Paris Diderot, IAME, Sorbonne Paris Cité, UMR 1137, Faculté De Médecine, Site Xavier Bichat, Paris, France.
Olga DanilchankaHarvard Medical School, Boston, MA.
Stéphanie PonsDivision of Infectious Diseases, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Laure DiancourtInstitut Pasteur, Genotyping of Pathogens and Public Health, Paris, France.
François LebretonHarvard Medical School, Boston, MA.
Kristina KadlecInstitute of Farm Animal Genetics, Friedrich-Loeffler-Institut (FLI), Neustadt-Mariensee, Germany.
Damien RouxDivision of Infectious Diseases, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA INSERM, IAME, UMR 1137, Paris, France Univ Paris Diderot, IAME, Sorbonne Paris Cité, UMR 1137, Faculté De Médecine, Site Xavier Bichat, Paris, France.
Deming JiangDivision of Infectious Diseases, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Sara DionINSERM, IAME, UMR 1137, Paris, France Univ Paris Diderot, IAME, Sorbonne Paris Cité, UMR 1137, Faculté De Médecine, Site Xavier Bichat, Paris, France.
Hugues AschardHarvard School of Public Health, Boston, MA.
Maurice DenamurINSERM, IAME, UMR 1137, Paris, France Univ Paris Diderot, IAME, Sorbonne Paris Cité, UMR 1137, Faculté De Médecine, Site Xavier Bichat, Paris, France.
Colette Cywes-BentleyDivision of Infectious Diseases, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Stefan SchwarzInstitute of Farm Animal Genetics, Friedrich-Loeffler-Institut (FLI), Neustadt-Mariensee, Germany.
Olivier TenaillonINSERM, IAME, UMR 1137, Paris, France Univ Paris Diderot, IAME, Sorbonne Paris Cité, UMR 1137, Faculté De Médecine, Site Xavier Bichat, Paris, France.
Antoine AndremontINSERM, IAME, UMR 1137, Paris, France Univ Paris Diderot, IAME, Sorbonne Paris Cité, UMR 1137, Faculté De Médecine, Site Xavier Bichat, Paris, France French National Reference Center for Bacterial Resistance in Commensal Flora, Laboratory of Bacteriology, Bichat-Claude Bernard Hospital, Assistance Publique-Hôpitaux De Paris, Paris, France.
Bertrand PicardINSERM, IAME, UMR 1137, Paris, France Univ Paris Nord, Sorbonne Paris Cité, UMR 1137, Faculté De Médecine, Site Xavier Bichat, Paris, France.
John MekalanosHarvard Medical School, Boston, MA.
Sylvain BrisseInstitut Pasteur, Genotyping of Pathogens and Public Health, Paris, France.
Erick DenamurINSERM, IAME, UMR 1137, Paris, France Univ Paris Diderot, IAME, Sorbonne Paris Cité, UMR 1137, Faculté De Médecine, Site Xavier Bichat, Paris, France dskurnik@rics.bwh.harvard.edu erick.denamur@inserm.fr.

Funding

COORDINATE REGULATION OF BACTERIAL VIRULENCE FACTORSR01AI026289 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI MEKALANOS, JOHN JOSEPH · 1988 to 2018
$8.3M
NIAID NIH HHS R01 AI026289
6 · The paper itself

Abstract

In the context of the great concern about the impact of human activities on the environment, we studied 403 commensal Escherichia coli/Escherichia clade strains isolated from several animal and human populations that have variable contacts to one another. Multilocus sequence typing (MLST) showed a decrease of diversity 1) in strains isolated from animals that had an increasing contact with humans and 2) in all strains that had increased antimicrobial resistance. A specific B1 phylogroup clonal complex (CC87, Institut Pasteur schema nomenclature) of animal origin was identified and characterized as being responsible for the increased antimicrobial resistance prevalence observed in strains from the environments with a high human-mediated antimicrobial pressure. CC87 strains have a high capacity of acquiring and disseminating resistance genes with specific metabolic and genetic determinants as demonstrated by high-throughput sequencing and phenotyping. They are good mouse gut colonizers but are not virulent. Our data confirm the predominant role of human activities in the emergence of antimicrobial resistance in the environmental bacterial strains and unveil a particular E. coli clonal complex of animal origin capable of spreading antimicrobial resistance to other members of microbial communities.

Indexed as

Genetic VariationAnimalsAnti-Infective AgentsDrug Resistance, Multiple, BacterialEscherichia coliEscherichia coli ProteinsGenotypeHumansMiceMultilocus Sequence TypingPhylogenyAnti-Infective AgentsEscherichia coli Proteinsantimicrobial resistanceclonal complex 87commensalEscherichia coliphylogroup B1

Identifiers

PMID26613786
PMCPMC5013867

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.